News

Light therapy has been trialed as a non-drug treatment option for fatigue in multiple sclerosis patients, with promising results.

Scientists have discovered that immune cells, known as microglia, help maintain the health of myelin.

Scientists have described and developed 3D models that recreate how an essential transcription factor, related to the progression of lung cancer and some types of leukemia in adults, binds to specific points in the genome to perform its function.

Researchers have used molecular profiling and machine learning to develop blood-based dietary signatures that more accurately predict both diet and the risk of cardiovascular disease and type 2 diabetes.

Researchers have tested three different treatment approaches theorized to slow the rate of aging, and found all to be ineffective in mice.

A new personalized cancer vaccine has demonstrated efficacy against melanoma in a Phase IIb clinical trial.

In a murine study, it was found that medicines usually used to treat angina and high blood pressure prevented much of the long-term damage caused by acute kidney injury.

People living with long COVID often report significant and persistent cognitive deficits collectively termed "brain fog". In a new, small study researchers—using their extensive experience with two existing medications—have published initial evidence that those drugs, given together, can mitigate or even eliminate brain fog.

A biomarker has been identified that can be used to predict the efficacy of a chemotherapeutic commonly used to treat breast cancer.

Two randomized, placebo-controlled trials evaluating three Ebola vaccine administration strategies in adults and children found that all the regimens were safe in both age groups.